Cash interventions to improve clinical outcomes for pulmonary tuberculosis: systematic review and meta-analysis

Aaron Richterman, Jonathan Steer-Massaro, Jana Jarolimova, Liem Binh Luong Nguyen, Jennifer Werdenberg, Louise C Ivers, Aaron Richterman, Jonathan Steer-Massaro, Jana Jarolimova, Liem Binh Luong Nguyen, Jennifer Werdenberg, Louise C Ivers

Abstract

Objective: To assess cash transfer interventions for improving treatment outcomes of active pulmonary tuberculosis in low- and middle-income countries.

Methods: We searched PubMed®, Embase®, Cochrane Library and ClinicalTrials.gov for studies published until 4 August 2017 that reported on cash transfer interventions during the treatment of active pulmonary tuberculosis in low- and middle-income countries. Our primary outcome was a positive clinical outcome, defined as treatment success, treatment completion or microbiologic cure. Using the purchasing power parity conversion factor, we converted the amount of cash received per patient within each study into international dollars (Int$). We calculated odds ratio (OR) for the primary outcome using a random effects meta-analysis.

Findings: Eight studies met eligibility criteria for review inclusion. Seven studies assessed a tuberculosis-specific intervention, with average amount of cash ranging from Int$ 193-858. One study assessed a tuberculosis-sensitive intervention, with average amount of Int$ 101. Four studies included non-cash co-interventions. All studies showed better primary outcome for the intervention group than the control group. After excluding three studies with high risk of bias, patients receiving tuberculosis-specific cash transfer were more likely to have a positive clinical outcome than patients in the control groups (OR: 1.77; 95% confidence interval: 1.57-2.01).

Conclusion: The evidence available suggests that patients in low- and middle-income countries receiving cash during treatment for active pulmonary tuberculosis are more likely to have a positive clinical outcome. These findings support the incorporation of cash transfer interventions into social protection schemes within tuberculosis treatment programmes.

Figures

Fig. 1
Fig. 1
Flowchart showing the selection of studies on cash interventions to improve tuberculosis clinical outcomes, 1991–2017
Fig. 2
Fig. 2
Publication bias of studies included in the meta-analysis on cash interventions to improve tuberculosis clinical outcomes, 1991–2017
Fig. 3
Fig. 3
Likelihood of a positive clinical outcome for tuberculosis-specific cash interventions to improve tuberculosis clinical outcomes, 1991–2017

References

    1. Global tuberculosis report. Geneva: World Health Organization; 2017. Available from: [cited 2017 Aug 16].
    1. Tanimura T, Jaramillo E, Weil D, Raviglione M, Lönnroth K. Financial burden for tuberculosis patients in low- and middle-income countries: a systematic review. Eur Respir J. 2014. June;43(6):1763–75. 10.1183/09031936.00193413
    1. Global strategy and targets for tuberculosis prevention, care and control after 2015: report by the Secretariat. Geneva: World Health Organization; 2013. Available from: [cited 2018 May 12].
    1. Combating poverty and inequality: structural change, social policy and politics. Geneva: United Nations Research Institute for Social Development; 2010.
    1. Garcia M, Moore CM. The cash dividend: the rise of cash transfer programs in sub-Saharan Africa. Washington, DC: The World Bank; 2012. 10.1596/978-0-8213-8897-6
    1. Boccia D, Pedrazzoli D, Wingfield T, Jaramillo E, Lönnroth K, Lewis J, et al. Towards cash transfer interventions for tuberculosis prevention, care and control: key operational challenges and research priorities. BMC Infect Dis. 2016. June 21;16(1):307. 10.1186/s12879-016-1529-8
    1. Boccia D, Hargreaves J, Lönnroth K, Jaramillo E, Weiss J, Uplekar M, et al. Cash transfer and microfinance interventions for tuberculosis control: review of the impact evidence and policy implications. Int J Tuberc Lung Dis. 2011. June;15(6) Suppl 2:37–49. 10.5588/ijtld.10.0438
    1. Hutton B, Salanti G, Caldwell DM, Chaimani A, Schmid CH, Cameron C, et al. The PRISMA extension statement for reporting of systematic reviews incorporating network meta-analyses of health care interventions: checklist and explanations. Ann Intern Med. 2015. June 2;162(11):777–84. 10.7326/M14-2385
    1. Fantom NJ, Serajuddin U. The World Bank's classification of countries by income. Policy Research working paper; no. WPS 7528. Washington, DC: World Bank Group; 2016.
    1. Definitions and reporting framework for tuberculosis: Geneva: World Health Organization; 2013 Available from: [cited 2017 Aug 16].
    1. World development indicators [internet]. Washington, DC: The World Bank; 2018. Available from: [cited 2018 Jan 5].
    1. Lönnroth K, Jaramillo E, Williams BG, Dye C, Raviglione M. Drivers of tuberculosis epidemics: the role of risk factors and social determinants. Soc Sci Med. 2009. June;68(12):2240–6. 10.1016/j.socscimed.2009.03.041
    1. Higgins J, Green S. Cochrane handbook for systematic reviews of interventions version 5.1.0. [updated March 2011]. London: The Cochrane Collaboration; 2011. Available from: [cited 2017 Aug 16].
    1. Wells G, Shea B, O’Connell D, Peterson J, Welch V, Losos M, et al. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. Ottawa: Ottawa Hospital Research Institute; 2011. Available from: [cited 2018 Jan 5].
    1. Wingfield T, Tovar MA, Huff D, Boccia D, Montoya R, Ramos E, et al. A randomized controlled study of socioeconomic support to enhance tuberculosis prevention and treatment, Peru. Bull World Health Organ. 2017. April 1;95(4):270–80. 10.2471/BLT.16.170167
    1. Ukwaja KN, Alobu I, Gidado M, Onazi O, Oshi DC. Economic support intervention improves tuberculosis treatment outcomes in rural Nigeria. Int J Tuberc Lung Dis. 2017. May 1;21(5):564–70. 10.5588/ijtld.16.0741
    1. Farmer P, Robin S, Ramilus SL, Kim JY. Tuberculosis, poverty, and “compliance”: lessons from rural Haiti. Semin Respir Infect. 1991. December;6(4):254–60.
    1. Ciobanu A, Domente L, Soltan V, Bivol S, Severin L, Plesca V, et al. Do incentives improve tuberculosis treatment outcomes in the Republic of Moldova? Public Health Action. 2014. October 21;4 Suppl 2:S59–63. 10.5588/pha.14.0047
    1. Lu H, Chen J, Wang W, Wu L, Shen X, Yuan Z, et al. Efforts to reduce the disparity between permanent residents and temporary migrants: Stop TB experiences in Shanghai, China. Trop Med Int Health. 2015. August;20(8):1033–40. 10.1111/tmi.12512
    1. Chirico MC, Kuriger AB, Etchevarria MH, Zerbini E, Casamajor ML. Economic subsidies for patients with tuberculosis and their relationship with treatment adherence. Salud i Ciencia. 2011;17(8):798–801.
    1. Rocha C, Montoya R, Zevallos K, Curatola A, Ynga W, Franco J, et al. The Innovative Socioeconomic Interventions Against Tuberculosis (ISIAT) project: an operational assessment. Int J Tuberc Lung Dis. 2011. June;15(6) Suppl 2:50–7. 10.5588/ijtld.10.0447
    1. Torrens AW, Rasella D, Boccia D, Maciel EL, Nery JS, Olson ZD, et al. Effectiveness of a conditional cash transfer programme on TB cure rate: a retrospective cohort study in Brazil. Trans R Soc Trop Med Hyg. 2016. March;110(3):199–206. 10.1093/trstmh/trw011
    1. High burden countries [internet]. Copenhagen: United Nations Office for Project Services; 2018. Available from: [cited 2017 Aug 30].
    1. An expanded DOTS framework for effective tuberculosis control. Int J Tuberc Lung Dis. 2002. May;6(5):378–88.
    1. Ranganathan M, Lagarde M. Promoting healthy behaviours and improving health outcomes in low and middle income countries: a review of the impact of conditional cash transfer programmes. Prev Med. 2012. November;55 Suppl:S95–105. 10.1016/j.ypmed.2011.11.015
    1. Wingfield T, Boccia D, Tovar M, Gavino A, Zevallos K, Montoya R, et al. Defining catastrophic costs and comparing their importance for adverse tuberculosis outcome with multi-drug resistance: a prospective cohort study, Peru. PLoS Med. 2014. July 15;11(7):e1001675. 10.1371/journal.pmed.1001675
    1. Rudgard WE, Evans CA, Sweeney S, Wingfield T, Lönnroth K, Barreira D, et al. Comparison of two cash transfer strategies to prevent catastrophic costs for poor tuberculosis-affected households in low- and middle-income countries: An economic modelling study. PLoS Med. 2017. November 7;14(11):e1002418. 10.1371/journal.pmed.1002418
    1. Pega F, Liu SY, Walter S, Pabayo R, Saith R, Lhachimi SK. Unconditional cash transfers for reducing poverty and vulnerabilities: effect on use of health services and health outcomes in low- and middle-income countries. Cochrane Database Syst Rev. 2017. November 15;11(11):CD011135.
    1. Owusu-Addo E, Cross R. The impact of conditional cash transfers on child health in low- and middle-income countries: a systematic review. Int J Public Health. 2014. August;59(4):609–18. 10.1007/s00038-014-0570-x
    1. Lagarde M, Haines A, Palmer N. The impact of conditional cash transfers on health outcomes and use of health services in low and middle income countries. Cochrane Database Syst Rev. 2009. October 7; (4):CD008137.
    1. Gopalan SS, Mutasa R, Friedman J, Das A. Health sector demand-side financial incentives in low- and middle-income countries: a systematic review on demand- and supply-side effects. Soc Sci Med. 2014. January;100(100):72–83. 10.1016/j.socscimed.2013.10.030
    1. Lutge EE, Wiysonge CS, Knight SE, Sinclair D, Volmink J. Incentives and enablers to improve adherence in tuberculosis. Cochrane Database Syst Rev. 2015. September 3;(9):CD007952.
    1. Cunha JM. Testing paternalism: cash versus in-kind transfers. Am Econ J Appl Econ. 2014;6(2):195–230. 10.1257/app.6.2.195
    1. Currie J, Gahvari F. Transfers in cash and in-kind: theory meets the data. J Econ Lit. 2008;46(2):333–83. 10.1257/jel.46.2.333
    1. Leroy JL, Gadsden P, Rodríguez-Ramírez S, de Cossío TG. Cash and in-kind transfers in poor rural communities in Mexico increase household fruit, vegetable, and micronutrient consumption but also lead to excess energy consumption. J Nutr. 2010. March;140(3):612–7. 10.3945/jn.109.116285
    1. van Hoorn R, Jaramillo E, Collins D, Gebhard A, van den Hof S. The effects of psycho-emotional and socioeconomic support for tuberculosis patients on treatment adherence and treatment outcomes: a systematic review and meta-analysis. PLoS One. 2016. April 28;11(4):e0154095. 10.1371/journal.pone.0154095
    1. Nery JS, Rodrigues LC, Rasella D, Aquino R, Barreira D, Torrens AW, et al. Effect of Brazil’s conditional cash transfer programme on tuberculosis incidence. Int J Tuberc Lung Dis. 2017. July 1;21(7):790–6. 10.5588/ijtld.16.0599

Source: PubMed

Sponsors and Collaborators

Medical Conditions

Drug Interventions

3
Subscribe